March 10, 2016
Nestle is conducting a two-year clinical study with data company Medidata in China to assess the impact of physical activity and nutrition on adults with joint discomfort. The study will use Garmin fitness trackers and a mobile app.
“The research program, developed in collaboration with dedicated experts from Nestle research centers in Lausanne and Beijing, is extending Medidata and Nestle...
March 9, 2016
Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.
2Morrow’s smoking cessation app, called SmartQuit, is based on acceptance and commitment therapy, or an ACT-based program, that "focuses on increasing one’s willingness to accept the physical, mental...
March 1, 2016
Baltimore, Maryland-based WellDoc has announced a collaboration with LifeScan, a Johnson and Johnson company that makes blood glucose meters. WellDoc also raised an additional $7.5 million from Johnson & Johnson Innovation and other investors, bringing the company’s total funding in its most recent round to $29.5 million.
Existing investors include Samsung Ventures, Merck Global Health...
February 26, 2016
The Medical Research Institute of New Zealand (MRINZ) has announced that it plans to launch an multi-country clinical study, called Novel START, using New Zealand-based Adherium’s connected inhalers. In addition to New Zealand, other study sites will be in Australia, the United Kingdom, and Italy.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop...
February 24, 2016
Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI).
"Patients and physicians deserve better designed inhalers that are easier to use and help them successfully treat their chronic respiratory disease,” David Van Sickle, CEO of Propeller, said in a...
February 16, 2016
Microsoft has announced a partnership Novartis that began a few years ago to create a system, called Assess MS, that better evaluates how patients perform on multiple sclerosis (MS) tests.
The current MS tests require patients to perform movements, like touching their nose or sitting with their arms outstretched. Providers watch the patients and rate their movements on a scale, but ratings that...
February 9, 2016
Novartis has signed deals with two major health plans, Cigna and Aetna, to reimburse for its new heart failure drug Entresto, Reuters reported. The deals are among the first publicly announced examples of outcomes-based drug pricing. While Novartis discussed using digital health devices as part of its planned Entresto rollout last year, reports about the new payer deals have not mentioned the...
February 2, 2016
Greyhealth group (ghg), a healthcare-focused agency owned by WPP that was a founding partner of Text4Baby and an early IBM Watson partner, has acquired The Lathe, a health app design and development firm, for an undisclosed amount.
"At ghg, we are focused on mobile health and believe technology and effective communication will significantly improve the lives of healthcare consumers and their...
January 21, 2016
According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology. Financial Times added in its report that the JV could be worth up to $1 billion.
Very little information about the prospective partnership is available, but it makes sense for both companies: Qualcomm has already teamed up with both Roche and Novartis on major...
January 12, 2016
There are many approaches to using digital technology to promote medication adherence, from tiny sensors embedded in pills to Bluetooth-connected pill boxes, to simple reminder apps. There’s something of a trade-off between hardware offerings, which provide real validation and accountability but can be expensive to deploy and scale, and software offerings, which are very easy to scale, but have a...